Skip to main content
Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
2.990
+0.140 (4.91%)
At close: Nov 6, 2024, 4:00 PM
3.000
+0.010 (0.33%)
Pre-market: Nov 7, 2024, 9:25 AM EST

Nexalin Technology Revenue

Nexalin Technology had revenue of $26.84K in the quarter ending June 30, 2024, a decrease of -24.48%. This brings the company's revenue in the last twelve months to $150.16K, down -76.89% year-over-year. In the year 2023, Nexalin Technology had annual revenue of $110.75K, down -91.62%.

Revenue (ttm)
$150.16K
Revenue Growth
-76.89%
P/S Ratio
148.30
Revenue / Employee
$25,027
Employees
6
Market Cap
31.65M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023110.75K-1.21M-91.62%
Dec 31, 20221.32M1.18M817.20%
Dec 31, 2021144.07K-98.85K-40.69%
Dec 31, 2020242.91K35.53K17.13%
Dec 31, 2019207.38K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FibroGen 173.82M
Outset Medical 114.73M
Celularity 33.52M
Lipocine 4.80M
Dyadic International 1.80M
Longeveron 1.23M
Revenue Rankings

NXL News

More News